| Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class Action - TMCI |
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. |
globenewswire.com |
2025-05-16 17:13:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Investors - Lead Plaintiff Deadline on June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148924&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 16:30:00 |
Czytaj oryginał (ang.) |
| Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI) |
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of all persons other than Defendants who purchased or otherwise acquired Treace Medical securities between May 8, 2023, and May 7, 2024, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Scott+Scott is captioned: McCluney v. Treace Medical Concepts, Inc., et al., Case No. 3:25-cv-00390. |
globenewswire.com |
2025-05-16 15:59:00 |
Czytaj oryginał (ang.) |
| TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors - Lead Plaintiff Deadline June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148892&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 14:00:00 |
Czytaj oryginał (ang.) |
| Faruqi & Faruqi Reminds Treace Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI |
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace Medical To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Treace Medical between May 8, 2023, and May 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , May 16, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) and reminds investors of the June 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. |
prnewswire.com |
2025-05-16 13:38:00 |
Czytaj oryginał (ang.) |
| Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky Before June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148813&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 13:15:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCI |
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Treace Medical Concepts, Inc ("Treace Medical" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. |
accessnewswire.com |
2025-05-16 13:00:00 |
Czytaj oryginał (ang.) |
| Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi & Korsinsky Urges Investors to Act Before June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148792&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 11:15:00 |
Czytaj oryginał (ang.) |
| TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! |
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Treace Medical securities between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"). |
accessnewswire.com |
2025-05-16 11:00:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Treace Medical Concepts, Inc.(TMCI) Shareholders |
NEW YORK , May 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. |
prnewswire.com |
2025-05-16 09:45:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Urges Treace Medical Concepts, Inc. (TMCI) Shareholders to Act Before Lead Plaintiff Deadline June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148772&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 02:45:00 |
Czytaj oryginał (ang.) |
| Investors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148757&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 22:45:00 |
Czytaj oryginał (ang.) |
| ROSEN, SKILLED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI |
NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / WHY: New York, N.Y., May 15, 2025. |
accessnewswire.com |
2025-05-15 22:12:00 |
Czytaj oryginał (ang.) |
| The Gross Law Firm Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 – TMCI |
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). |
globenewswire.com |
2025-05-15 17:56:00 |
Czytaj oryginał (ang.) |
| Class Action Lawsuit Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148712&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 16:30:00 |
Czytaj oryginał (ang.) |
| Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky Before June 10, 2025 |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148690&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 14:30:00 |
Czytaj oryginał (ang.) |
| June 10, 2025 Deadline: Join Class Action Lawsuit Against Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148630&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 11:15:00 |
Czytaj oryginał (ang.) |
| TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! |
NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Treace Medical securities between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"). |
accessnewswire.com |
2025-05-15 11:00:00 |
Czytaj oryginał (ang.) |
| June 10, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against TMCI |
NEW YORK , May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. |
prnewswire.com |
2025-05-15 09:45:00 |
Czytaj oryginał (ang.) |
| Class Action Lawsuit Filed: Treace Medical Concepts, Inc. (TMCI) – Join by June 10, 2025 – Contact Levi & Korsinsky |
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148597&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 03:05:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates |
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.10 per share a year ago. |
zacks.com |
2025-02-27 21:25:24 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-25 12:00:00 |
Czytaj oryginał (ang.) |
| An Investigation Has Been Launched Into Treace Medical Concepts, Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-24 12:00:00 |
Czytaj oryginał (ang.) |
| An Investigation Has Been Launched Into Treace Medical Concepts, Inc. For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-22 12:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-21 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-20 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-19 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-18 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-17 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-16 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-15 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-14 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-13 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 11, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-11 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-10 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-09 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-08 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation |
LOS ANGELES, CA / ACCESS Newswire / February 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-07 13:00:00 |
Czytaj oryginał (ang.) |
| Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 |
PONTE VEDRA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that it will release financial results for the fourth quarter and full year of 2024 after the close of trading on Thursday, February 27, 2025. Company management will host a conference call to discuss financial results beginning at 4:30 pm ET. |
globenewswire.com |
2025-02-06 18:15:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accessnewswire.com |
2025-02-06 13:00:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2025-01-04 13:15:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / January 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2025-01-03 15:15:00 |
Czytaj oryginał (ang.) |
| Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference |
PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, beginning at approximately 9:00 am PT. |
globenewswire.com |
2025-01-02 18:15:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / January 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2025-01-02 15:45:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-31 14:30:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-30 13:30:00 |
Czytaj oryginał (ang.) |
| Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure |
Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base |
globenewswire.com |
2024-12-30 10:15:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-29 13:30:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-28 14:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-27 15:45:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-26 13:30:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-24 12:45:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-23 13:00:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-21 14:30:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-20 16:15:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-19 12:30:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-18 15:45:00 |
Czytaj oryginał (ang.) |
| The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud |
LOS ANGELES, CA / ACCESSWIRE / December 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-17 15:30:00 |
Czytaj oryginał (ang.) |
| Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm |
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. |
accesswire.com |
2024-12-16 15:15:00 |
Czytaj oryginał (ang.) |
| Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant |
PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced the successful completion of the first cases utilizing SpeedPlate™ MicroQuad™ implants. |
globenewswire.com |
2024-12-16 10:30:00 |
Czytaj oryginał (ang.) |